{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T08:55:46Z","timestamp":1768812946185,"version":"3.49.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.humpath.2011.08.002","type":"journal-article","created":{"date-parts":[[2011,12,12]],"date-time":"2011-12-12T23:45:47Z","timestamp":1323733547000},"page":"904-910","source":"Crossref","is-referenced-by-count":26,"title":["Expression of CXCR4 indicates poor prognosis in patients with clear cell carcinoma of the ovary"],"prefix":"10.1016","volume":"43","author":[{"given":"Ryuichiro","family":"Sekiya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Kajiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kotaro","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomokazu","family":"Umezu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mika","family":"Mizuno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyosumi","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiko","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sawako","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuro","family":"Nagasaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumitaka","family":"Kikkawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2011.08.002_bb0005","series-title":"International histological classification of tumors. No 9. Histologic typing of ovarian tumors","author":"Serov","year":"1973"},{"key":"10.1016\/j.humpath.2011.08.002_bb0010","series-title":"Surgical pathology of the ovaries","author":"Rusell","year":"1989"},{"key":"10.1016\/j.humpath.2011.08.002_bb0015","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/0090-8258(89)90637-9","article-title":"Ovarian clear cell adenocarcinoma","volume":"32","author":"Kennedy","year":"1989","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.humpath.2011.08.002_bb0020","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1002\/1097-0142(20000601)88:11<2584::AID-CNCR22>3.3.CO;2-X","article-title":"Clinical characteristics of clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy","volume":"88","author":"Sugiyama","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2011.08.002_bb0025","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1006\/gyno.1996.0065","article-title":"Clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy in stage III disease","volume":"60","author":"Goff","year":"1996","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.humpath.2011.08.002_bb0030","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1006\/gyno.1993.1117","article-title":"Clear cell epithelial ovarian cancer (mesonephroid): bad prognosis only in early stages","volume":"49","author":"O'Brien","year":"1993","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.humpath.2011.08.002_bb0035","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1006\/gyno.1998.5071","article-title":"Clinical characteristics of clear cell carcinoma of the ovary","volume":"70","author":"Behbakht","year":"1998","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.humpath.2011.08.002_bb0040","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ygyno.2005.12.038","article-title":"Advanced stage clear-cell epithelial ovarian cancer: the Hellenic Cooperative Oncology Group experience","volume":"102","author":"Pectasides","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.humpath.2011.08.002_bb0045","first-page":"1969","article-title":"Stromal cell-derived factor 1alpha stimulates human glioblastoma cell growth through the activation of both extracellular signal-regulated kinases 1\/2 and Akt","volume":"63","author":"Barbero","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2011.08.002_bb0050","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1182\/blood-2002-01-0031","article-title":"CXCR4-SDF-1 signaling is active in rhabdomyosarcoma cells and regulates locomotion, chemotaxis, and adhesion","volume":"100","author":"Libura","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2011.08.002_bb0055","first-page":"7328","article-title":"Expression of CXC chemokine receptor-4 enhances the pulmonary metastatic potential of murine B16 melanoma cells","volume":"62","author":"Murakami","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2011.08.002_bb0060","first-page":"5930","article-title":"Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer","volume":"62","author":"Scotton","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2011.08.002_bb0065","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1164\/rccm.200301-071OC","article-title":"The stromal derived factor-1\/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases","volume":"167","author":"Phillips","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.humpath.2011.08.002_bb0070","first-page":"4961","article-title":"Epithelial cancer cell migration: a role for chemokine receptors?","volume":"61","author":"Scotton","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2011.08.002_bb0075","doi-asserted-by":"crossref","unstructured":"Miyanishi N, Suzuki Y, Simizu S, Kuwabara Y, Banno K, Umezawa K. Involvement of autocrine CXCL12\/CXCR4 system in the regulation of ovarian carcinoma cell invasion. Biochem Biophys Res Commun 403:154-9.","DOI":"10.1016\/j.bbrc.2010.11.007"},{"key":"10.1016\/j.humpath.2011.08.002_bb0080","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/ijc.23083","article-title":"Involvement of SDF-1alpha\/CXCR4 axis in the enhanced peritoneal metastasis of epithelial ovarian carcinoma","volume":"122","author":"Kajiyama","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.humpath.2011.08.002_bb0085","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/00004347-200304000-00010","article-title":"Neutral endopeptidase\/CD10 expression in the stroma of epithelial ovarian carcinoma","volume":"22","author":"Khin","year":"2003","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.humpath.2011.08.002_bb0090","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.ygyno.2008.02.006","article-title":"Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers","volume":"109","author":"Chan","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.humpath.2011.08.002_bb0095","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ygyno.2006.02.036","article-title":"Expression of chemokine CXCL12 and its receptor CXCR4 in human epithelial ovarian cancer: an independent prognostic factor for tumor progression","volume":"103","author":"Jiang","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.humpath.2011.08.002_bb0100","doi-asserted-by":"crossref","unstructured":"Singh S, Srivastava SK, Bhardwaj A, Owen LB, Singh AP. CXCL12-CXCR4 signalling axis confers gemcitabine resistance to pancreatic cancer cells: a novel target for therapy. Br J Cancer 103:1671-9.","DOI":"10.1038\/sj.bjc.6605968"},{"key":"10.1016\/j.humpath.2011.08.002_bb0105","doi-asserted-by":"crossref","unstructured":"Dessein AF, Stechly L, Jonckheere N, et al. Autocrine induction of invasive and metastatic phenotypes by the MIF-CXCR4 axis in drug-resistant human colon cancer cells. Cancer Res 70:4644-54.","DOI":"10.1158\/0008-5472.CAN-09-3828"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817711003364?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817711003364?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T16:21:55Z","timestamp":1543335715000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817711003364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S0046817711003364"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2011.08.002","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}